Basic Information
RNALocate ID: | RLID:01002788 |
RNA Symbol: | hsa-miR-1275 |
Localization: | Mitochondrion |
RNA Information
RNA Name: | hsa-miR-1275 |
RNA ID: | miRBase:MIMAT0005929 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 21695135 |
Tissue/Cell Line: | Cell line (HeLa) |
Method: | Microarray |
Heatmap showing the 57 miRNAs differentially expressed in HeLa cells from mitochondrial and cytosolic RNA. Three independent microarray profiling experiments (microarray n1, n2 and n3) are shown and reproducibly revealed 13 miRNAs enriched in mitochondrial RNA. Originally published in PLoS One. Bandiera S, et al, 2011. Reproduced under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) |
|
Description: | While 44 miRNAs showed a greater enrichment in the cytosolic Hy3-labeled RNA fraction, 13 miRNAs were significantly and reproducibly enriched in the mitochondrial Hy5-labeled RNA sample (ranging from 1.5- to 56-fold), namely hsa-miR-1973, hsa-miR-1275, hsa-miR-494, hsa-miR-513a-5p, hsa-miR-1246, hsa-miR-328, hsa-miR-1908, hsa-miR-1972, hsa-miR-1974, hsa-miR-1977, hsa-miR-638, hsa-miR-1978 and hsa-miR-1201 (Figure 5A). Data are collected from Figure 5. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002786 | Mitochondrion | HeLa cells | 27396686 |
RLID:01002787 | Mitochondrion | HeLa cells | 27563705 |
RLID:01002789 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01002790 | Nucleolus | HeLa cells | 23940654 |
RLID:01002837 | Cytosol | Cell line (HeLa) | 21695135 |
RLID:01002838 | Mitochondrion | Cell line (HeLa) | 21695135 |
RLID:11004346 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
RLID:11004347 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
RLID:11004348 | Microvesicle | Seminal plasma | 23539611 |
RLID-D:11000791 | Microvesicle | Colon cancer cell line (LIM1863)|Mesenchymal stem cells | |
RLID-D:11001721 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-1275 | Oral squamous cell carcinoma | MNDR-E-MI-08791 |
MNDR | hsa-miR-1275 | Estrogen-receptor positive breast cancer | MNDR-E-MI-08792 |
MNDR | hsa-miR-1275 | Estrogen-receptor negative breast cancer | MNDR-E-MI-08793 |
MNDR | hsa-miR-1275 | Progesterone-receptor positive breast cancer | MNDR-E-MI-08794 |
MNDR | hsa-miR-1275 | Progesterone-receptor negative breast cancer | MNDR-E-MI-08795 |
MNDR | hsa-miR-1275 | Her2-receptor positive breast cancer | MNDR-E-MI-08796 |
MNDR | hsa-miR-1275 | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-08797 |
MNDR | hsa-mir-1275 | Colorectal carcinoma | MNDR-E-MI-08798 |
MNDR | hsa-miR-1275 | B cell acute lymphoblastic leukemia | MNDR-E-MI-08799 |
MNDR | hsa-miR-1275 | Prostate cancer | MNDR-E-MI-08800 |
MNDR | hsa-miR-1275 | Alzheimer disease | MNDR-E-MI-08801 |
MNDR | hsa-miR-1275 | Intracranial aneurysm | MNDR-E-MI-08802 |
MNDR | hsa-miR-1275 | Polycystic ovary syndrome | MNDR-E-MI-08803 |
MNDR | hsa-miR-1275 | Head and neck cancer | MNDR-E-MI-08804 |
MNDR | hsa-miR-1275 | Lung cancer | MNDR-E-MI-08805 |
MNDR | hsa-miR-1275 | Parkinson disease | MNDR-E-MI-08806 |
MNDR | hsa-miR-1275 | Breast cancer | MNDR-E-MI-08807 |
MNDR | hsa-mir-1275 | Squamous carcinoma | MNDR-E-MI-08808 |
MNDR | hsa-miR-1275 | Pancreatic cancer | MNDR-E-MI-08809 |
MNDR | hsa-miR-1275 | Nephroblastoma | MNDR-E-MI-08810 |
MNDR | hsa-miR-1275 | Multiple sclerosis | MNDR-E-MI-08811 |
MNDR | hsa-miR-1275 | Multiple sclerosis relapsing-remitting | MNDR-E-MI-08812 |
MNDR | hsa-miR-1275 | Ovarian cancer | MNDR-E-MI-08813 |
MNDR | hsa-miR-1275 | Glioma | MNDR-E-MI-08814 |
MNDR | hsa-miR-1275 | Amyotrophic lateral sclerosis | MNDR-E-MI-08815 |
MNDR | hsa-miR-1275 | Liver cancer | MNDR-E-MI-08816 |
MNDR | hsa-mir-1275 | Non-small cell lung cancer | MNDR-E-MI-08817 |
MNDR | hsa-miR-1275 | Lung adenocarcinoma | MNDR-E-MI-08818 |
MNDR | hsa-miR-1275 | Thyroid carcinoma | MNDR-E-MI-08819 |
MNDR | hsa-miR-1275 | Pancreatic adenocarcinoma | MNDR-E-MI-08820 |
MNDR | hsa-miR-1275 | Intrahepatic cholangiocarcinoma | MNDR-E-MI-08821 |
MNDR | hsa-miR-1275 | Cholangiocarcinoma | MNDR-E-MI-08822 |
MNDR | hsa-miR-1275 | Adenoma | MNDR-E-MI-08823 |
MNDR | hsa-miR-1275 | Progressive supranuclear palsy | MNDR-E-MI-08824 |
MNDR | hsa-mir-1275 | Carcinoma hepatocellular | MNDR-E-MI-08825 |
MNDR | hsa-miR-1275 | Hepatocellular carcinoma | MNDR-E-MI-08826 |
MNDR | hsa-miR-1275 | Hodgkin lymphoma | MNDR-E-MI-08827 |
MNDR | hsa-miR-1275 | Acute myelocytic leukemia | MNDR-E-MI-08828 |
MNDR | hsa-mir-1275 | Colorectal cancer | MNDR-E-MI-08829 |
MNDR | hsa-mir-1275 | Nasopharyngeal carcinoma | MNDR-E-MI-08830 |
MNDR | hsa-miR-1275 | Nasopharynx carcinoma | MNDR-E-MI-08831 |
MNDR | hsa-miR-1275 | Nasopharyngeal cancer | MNDR-E-MI-08832 |
MNDR | hsa-miR-1275 | Pseudorabies | MNDR-E-MI-08833 |
MNDR | hsa-miR-1275 | Subarachnoid hemorrhage traumatic | MNDR-E-MI-08834 |
MNDR | hsa-miR-1275 | Stroke lacunar | MNDR-E-MI-08835 |
MNDR | hsa-miR-1275 | Breast cancer her3+ negative | MNDR-E-MI-08836 |
MNDR | hsa-mir-1275 | Multiple sclerosis susceptibility | MNDR-E-MI-08837 |
MNDR | hsa-mir-1275 | Stroke susceptibility | MNDR-E-MI-08838 |
MNDR | hsa-miR-1275 | Tubulovillous adenoma | MNDR-E-MI-08839 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | AK3 | Homo sapiens | RR00064570 |
TOP